Core Viewpoint - Meizhou Health International (02327) reported a mixed performance for the six months ending June 30, 2025, with a significant decrease in revenue but a notable increase in profit attributable to shareholders [1] Financial Performance - The company achieved revenue of HKD 17.453 million, a year-on-year decrease of 41.89% [1] - Profit attributable to shareholders was HKD 15.157 million, reflecting a year-on-year increase of 79.05% [1] - Earnings per share stood at HKD 0.37 [1] Profit Analysis - The after-tax profit for the six months ending June 30, 2025, was approximately HKD 15.1 million, up about HKD 6.9 million or approximately 84.1% compared to HKD 8.2 million for the same period in 2024 [1] - The increase in profit was primarily due to: - Growth in property-related business revenue and profit, with rental income rising from approximately HKD 8.2 million to about HKD 10 million [1] - Interest income increased from approximately HKD 8.9 million to about HKD 14.8 million [1] - Positive financial impact from foreign exchange gains, which rose from approximately HKD 4.4 million to about HKD 5.8 million [1]
美瑞健康国际(02327)发布中期业绩，股东应占溢利1515.7万港元 同比增加79.05%